<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="http://www.ri.gov/rss/ri_rss.xsl"?>
<rss version="2.0">
  <channel>
    <title>Department of Health: Communicable Diseases</title>
    <link>http://www.health.ri.gov/</link>
    <description>Department of Health: Communicable Diseases - News</description>
    <language>en-us</language>
    <webMaster>rihelp@egov.com</webMaster>
    <item>
      <title>China H7N9 Avian Influenza Update, Prepared by the Yale/Tulane Planning and Response Program</title>
      <description>The Yale/Tulane Planning and Response Program, in conjunction with the Yale University Department of Emergency Medicine, has produced this special report as a result of the recent outbreaks in China involving Avian Influenza (H7N9). This power point presentation was compiled entirely from open...</description>
      <pubDate>Thu, 25 Apr 2013 13:34:45 GMT</pubDate>
      <link>http://www.slideshare.net/fullscreen/YALE-ESF8--VMOC/yale-tulane-esf8-special-report-ah7n9-virus/1</link>
    </item>
    <item>
      <title>Nationwide Shortage of Tuberculin Skin test Antigens: CDC Recommendations for Patient Care and Public Health Practice</title>
      <description>A manufacturer of purified protein derivative (PPD) used in the tuberculin skin test (TST) is experiencing delays in production of Tubersol, resulting in a nationwide shortage expected to last through the end of May 2013. Additionally, the manufacturer for APLISOL is also expecting shortages to...</description>
      <pubDate>Fri, 12 Apr 2013 18:32:36 GMT</pubDate>
      <link>http://www.bt.cdc.gov/HAN/han00345.asp</link>
    </item>
    <item>
      <title>CDC Travel Advisory: China Reports First Human Infections with Novel Influenza A (H7N9) Virus</title>
      <description>All physicians who see patients with influenza illness in travelers returning from China -- regardless of season -- should contact the Rhode Island Department of Health (HEALTH) Division of Infectious Disease and Epidemiology at (401) 222-2577. As of April 4, 2013, public health officials in China...</description>
      <pubDate>Tue, 09 Apr 2013 12:53:09 GMT</pubDate>
      <link>http://emergency.cdc.gov/HAN/han00344.asp </link>
    </item>
    <item>
      <title>CDC Press Release: Action Needed Now to Halt Spread of Deadly Bacteria</title>
      <description>On Tuesday, March 5, the Centers for Disease Control and Prevention (CDC) released a press release calling upon the entire health care community to work urgently – individually, regionally, and nationally – to protect patients against Carbapenem-Resistant Enterobacteriaceae (CRE). The announcement...</description>
      <pubDate>Tue, 05 Mar 2013 20:16:49 GMT</pubDate>
      <link>http://www.cdc.gov/media/releases/2013/p0305_deadly_bacteria.html</link>
    </item>
    <item>
      <title>CDC Update to Clinicians: Continued Vigilance Urged for Fungal Infections among Patients Who Received Contaminated Steroid Injections</title>
      <description>Summary of CDCHAN-00342: CDC continues to receive new reports of fungal infection among patients who were given injections of contaminated methylprednisolone acetate (MPA1) from the New England Compounding Center (NECC) in Framingham, Mass. Most of these recent cases have been localized spinal or...</description>
      <pubDate>Tue, 05 Mar 2013 15:55:45 GMT</pubDate>
      <link>http://emergency.cdc.gov/HAN/han00342.asp</link>
    </item>
    <item>
      <title>     CDC HAN Advisory: New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers</title>
      <description>This is an official CDC Health Advisory distributed via the Health Alert Network on February 14, 2013 at 12:30:00 ET (CDCHAN-00341). Summary: Carbapenem-resistant Enterobacteriaceae (CRE) are untreatable or difficult-to-treat multidrug-resistant organisms that are emerging in the United States....</description>
      <pubDate>Thu, 28 Feb 2013 14:04:32 GMT</pubDate>
      <link>http://www.bt.cdc.gov/HAN/han00341.asp</link>
    </item>
    <item>
      <title>Update: Multistate Outbreak of Fungal Infections among Persons Who Received Injections with Contaminated Medication</title>
      <description>Healthcare providers should be aware that out of an abundance of caution HEALTH continues to follow up with patients exposed to contaminated methylprednisolone acetate (MPA1) from the New England Compounding Center (NECC) in Framingham, Mass. Any concerns over lingering infections may result in...</description>
      <pubDate>Mon, 11 Feb 2013 15:21:08 GMT</pubDate>
      <link>http://www.health.ri.gov/news/infectiousdisease/index.php</link>
    </item>
    <item>
      <title>CDC Update: Doxycycline Shortage Results in Alternative Treatment Recommendations for Sexually Transmitted Infections</title>
      <description>The Food and Drug Administration (FDA) reported a shortage of doxycycline on January 18, 2013. Doxycycline is a recommended therapy for some sexually transmitted infections and syndromes including chlamydia, nongonococcal urethritis, epididymitis and pelvic inflammatory disease and as an...</description>
      <pubDate>Mon, 11 Feb 2013 15:20:23 GMT</pubDate>
      <link>http://www.cdc.gov/std/treatment/doxycyclineShortage.htm?s_CID=govd-std-004 </link>
    </item>
    <item>
      <title>Nationwide Shortages of Both Tuberculin and INH are Currently Affecting Rhode Island</title>
      <description>Manufacturers of purified protein derivative (PPD) used in the tuberculin skin test (TST) are experiencing delays in production resulting in a nationwide shortage. Additionally, There is an ongoing, nationwide shortage of Isoniazid (INH) 300 mg and other formulations of INH (100 mg tabs, Rifamate,...</description>
      <pubDate>Mon, 11 Feb 2013 15:02:31 GMT</pubDate>
      <link>http://www.health.ri.gov/publications/advisories/20120208TBALERTNationwideShortagesofPPDandINH.pdf </link>
    </item>
    <item>
      <title>CDC HAN 340: Recommendations for Drug Allocation, Tuberculosis Prevention, and Patient Care During Isoniazid Shortages</title>
      <description>Shortages of isoniazid (INH), a cornerstone drug for treating tuberculosis disease (TB) and latent Mycobacterium tuberculosisinfection (LTBI), are continuing. This notice gives an update on the shortages and expands general guidance about how to adjust practices in response to the shortages from...</description>
      <pubDate>Wed, 06 Feb 2013 17:47:31 GMT</pubDate>
      <link>http://emergency.cdc.gov/HAN/han00340.asp </link>
    </item>
    <item>
      <title>Guidance for Interpreting Results from the Abbott HIV Ab/Ag Combo Test</title>
      <description>The Rhode Island State Health Laboratory (RISHL) instituted a new HIV screening test two years ago which is called the Abbott HIV Ab/Ag Combo test. This test is capable of detecting HIV infections earlier than the previous generation Abbott test utilized at the RISHL, giving us the capacity to...</description>
      <pubDate>Wed, 06 Feb 2013 17:45:29 GMT</pubDate>
      <link>http://www.health.ri.gov/publications/guidance/AbbottHIVAbAgComboTestingInterpretation.pdf </link>
    </item>
    <item>
      <title>HEALTH Advisory: Coventry Pertussis Cases</title>
      <description>The Rhode Island Department of Health (HEALTH) has confirmed two cases of pertussis in Coventry involving two Grade 6 students at the Alan Shawn Feinstein Middle School. We are working with the schools and families to identify and recommend prophylaxis for close contacts and high-risk individuals....</description>
      <pubDate>Wed, 16 Jan 2013 15:20:04 GMT</pubDate>
      <link>http://us2.campaign-archive1.com/?u=ece9b1661b3bf3b864a6894d1&amp;id=2b4608c2ce</link>
    </item>
  </channel>
</rss>
